Creative Financial Designs’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-13
Closed -$4.27K 2056
2024
Q4
$4.27K Hold
13
﹤0.01% 1461
2024
Q3
$4.35K Hold
13
﹤0.01% 1411
2024
Q2
$3.55K Hold
13
﹤0.01% 1391
2024
Q1
$4.5K Hold
13
﹤0.01% 1330
2023
Q4
$4.2K Hold
13
﹤0.01% 1292
2023
Q3
$4.66K Hold
13
﹤0.01% 1202
2023
Q2
$4.93K Hold
13
﹤0.01% 1181
2023
Q1
$6.23K Hold
13
﹤0.01% 1066
2022
Q4
$5.47K Hold
13
﹤0.01% 1021
2022
Q3
$5K Hold
13
﹤0.01% 1018
2022
Q2
$6K Hold
13
﹤0.01% 959
2022
Q1
$7K Hold
13
﹤0.01% 970
2021
Q4
$10K Sell
13
-73
-85% -$54.6K ﹤0.01% 897
2021
Q3
$64K Hold
86
0.01% 548
2021
Q2
$55K Hold
86
0.01% 578
2021
Q1
$49K Hold
86
0.01% 569
2020
Q4
$50K Hold
86
0.01% 510
2020
Q3
$44K Hold
86
0.01% 487
2020
Q2
$39K Buy
+86
New +$38K 0.01% 458
2018
Q4
Sell
-13
Closed -$4K 595
2018
Q3
$4K Hold
13
﹤0.01% 549
2018
Q2
$4K Hold
13
﹤0.01% 567
2018
Q1
$3K Hold
13
﹤0.01% 548
2017
Q4
$3K Hold
13
﹤0.01% 549
2017
Q3
$3K Hold
13
﹤0.01% 572
2017
Q2
$3K Hold
13
﹤0.01% 578
2017
Q1
$3K Hold
13
﹤0.01% 541
2016
Q4
$2K Buy
+13
New +$2.22K ﹤0.01% 570

Other funds holding BIO

Creative Financial Designs's BIO Position: Q1 2025 in Review

Creative Financial Designs sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2025, closing a stake of 13 shares — an estimated $4.27K sold.

Creative Financial Designs first reported a position in BIO in Q4 2016 and held it in 27 quarters. The position peaked at $64K in Q3 2021. 436 funds tracked by Wall St. Rank hold BIO as of Q1 2025.

  • Creative Financial Designs reported no remaining Bio-Rad Laboratories Class A position as of Q1 2025 after selling out during the quarter.
  • Creative Financial Designs sold 13 Bio-Rad Laboratories Class A shares in Q1 2025, an estimated $4.27K.
  • Creative Financial Designs first reported a position in Bio-Rad Laboratories Class A in Q4 2016 and held it in 27 quarters.
  • Creative Financial Designs's Bio-Rad Laboratories Class A position peaked at $64K in Q3 2021.
  • 436 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2025.

Based on Creative Financial Designs's 13F filing for Q1 2025, filed 23 Apr 2025.